Select committee: Finance Bill Sub-Committee

Recommendation 11

3rd Report - Research and development tax relief and expenditure credit Published 31 Jan 2023 Paragraph 83
Recommendation (the committee's words)
We recommend that HMRC monitors whether compliance with the requirement for a senior officer of a company to endorse an R&D claim, as well as the company’s own tax return, achieves the policy aim of this measure. If it proves necessary, HMRC should consider what other options might be available to ensure senior officers of companies take appropriate responsibility for claims.

From: Finance Bill Sub-Committee, 3rd Report - Research and development tax relief and expenditure credit, paragraph 83, 31 January 2023

Government response

The government responded to the whole report on 13 April 2023 (deadline 31 March 2023).

Summary written by Accountability Index from the government's response. It is not the government's own words.

The Government thanks the Committee and "notes its conclusions and recommendations", accepting some recommendations in full, some partially, and not accepting others.

  • It does not accept the recommendation to drop the six-month claim notification requirement, saying it responds to "high levels of error and fraud" and limits "bulk claims for multiple earlier years".
  • It does not accept the recommendation that relief payments carry a warning about later recovery, saying existing guidance gives "sufficient warning" and a new customer contact point would add resource and IT costs.
  • On overseas expenditure, it partially accepts the call for transitional relief. The restriction now starts on 1 April 2024, with narrow exemptions, and it does not think further exemptions are necessary.
  • On a merged R&D scheme, the Government is "currently considering the responses and no decision has been made", and intends "to keep open the option" of a merged scheme from April 2024.

Read the government's response ↗ Report an error